These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 26695142)
41. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Zheng B; Liang L; Wang C; Huang S; Cao X; Zha R; Liu L; Jia D; Tian Q; Wu J; Ye Y; Wang Q; Long Z; Zhou Y; Du C; He X; Shi Y Clin Cancer Res; 2011 Dec; 17(24):7574-83. PubMed ID: 21994419 [TBL] [Abstract][Full Text] [Related]
42. miR-448 suppressed gastric cancer proliferation and invasion by regulating ADAM10. Wu X; Tang H; Liu G; Wang H; Shu J; Sun F Tumour Biol; 2016 Aug; 37(8):10545-51. PubMed ID: 26852749 [TBL] [Abstract][Full Text] [Related]
43. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN. Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551 [TBL] [Abstract][Full Text] [Related]
44. MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer. Liu Q; Wang W; Yang X; Zhao D; Li F; Wang H Oncol Rep; 2016 Jul; 36(1):189-96. PubMed ID: 27175941 [TBL] [Abstract][Full Text] [Related]
45. MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer. Luo LJ; Yang F; Ding JJ; Yan DL; Wang DD; Yang SJ; Ding L; Li J; Chen D; Ma R; Wu JZ; Tang JH Gene; 2016 Dec; 594(1):47-58. PubMed ID: 27593563 [TBL] [Abstract][Full Text] [Related]
46. MicroRNA-27b reverses docetaxel resistance of non-small cell lung carcinoma cells via targeting epithelial growth factor receptor. Chen S; Wang Q; Zhou XM; Zhu JP; Li T; Huang M Mol Med Rep; 2016 Jul; 14(1):949-54. PubMed ID: 27221512 [TBL] [Abstract][Full Text] [Related]
47. miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2. Shi L; Wang Z; Sun G; Wan Y; Guo J; Fu X Neuromolecular Med; 2014 Jun; 16(2):517-28. PubMed ID: 24777293 [TBL] [Abstract][Full Text] [Related]
48. MiR-195 suppresses non-small cell lung cancer by targeting CHEK1. Liu B; Qu J; Xu F; Guo Y; Wang Y; Yu H; Qian B Oncotarget; 2015 Apr; 6(11):9445-56. PubMed ID: 25840419 [TBL] [Abstract][Full Text] [Related]
49. Decreased Expression of MiRNA-204-5p Contributes to Glioma Progression and Promotes Glioma Cell Growth, Migration and Invasion. Xia Z; Liu F; Zhang J; Liu L PLoS One; 2015; 10(7):e0132399. PubMed ID: 26134825 [TBL] [Abstract][Full Text] [Related]
50. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells. Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182 [TBL] [Abstract][Full Text] [Related]
51. Down-regulation of miR-605 promotes the proliferation and invasion of prostate cancer cells by up-regulating EN2. Zhou YJ; Yang HQ; Xia W; Cui L; Xu RF; Lu H; Xue Z; Zhang B; Tian ZN; Cao YJ; Xing ZY; Yin S; He XZ Life Sci; 2017 Dec; 190():7-14. PubMed ID: 28943214 [TBL] [Abstract][Full Text] [Related]
52. MiR-639 promoted cell proliferation and cell cycle in human thyroid cancer by suppressing CDKN1A expression. Lei ST; Shen F; Chen JW; Feng JH; Cai WS; Shen L; Hu ZW; Xu B Biomed Pharmacother; 2016 Dec; 84():1834-1840. PubMed ID: 27829546 [TBL] [Abstract][Full Text] [Related]
53. microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Zhao JJ; Lin J; Lwin T; Yang H; Guo J; Kong W; Dessureault S; Moscinski LC; Rezania D; Dalton WS; Sotomayor E; Tao J; Cheng JQ Blood; 2010 Apr; 115(13):2630-9. PubMed ID: 20086245 [TBL] [Abstract][Full Text] [Related]
54. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells. Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261 [TBL] [Abstract][Full Text] [Related]
55. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity. Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739 [TBL] [Abstract][Full Text] [Related]
56. MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGFβR2. Ma ZL; Hou PP; Li YL; Wang DT; Yuan TW; Wei JL; Zhao BT; Lou JT; Zhao XT; Jin Y; Jin YX Tumour Biol; 2015 Apr; 36(4):2481-90. PubMed ID: 25501507 [TBL] [Abstract][Full Text] [Related]
57. MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2. Wu Q; Guo R; Lin M; Zhou B; Wang Y Gynecol Oncol; 2011 Jul; 122(1):149-54. PubMed ID: 21529905 [TBL] [Abstract][Full Text] [Related]
58. miR-490-3p inhibits the growth and invasiveness in triple-negative breast cancer by repressing the expression of TNKS2. Jia Z; Liu Y; Gao Q; Han Y; Zhang G; Xu S; Cheng K; Zou W Gene; 2016 Nov; 593(1):41-47. PubMed ID: 27506313 [TBL] [Abstract][Full Text] [Related]
59. miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells. Lei Y; Li B; Tong S; Qi L; Hu X; Cui Y; Li Z; He W; Zu X; Wang Z; Chen M PLoS One; 2015; 10(2):e0117809. PubMed ID: 25658842 [TBL] [Abstract][Full Text] [Related]